Peer-reviewed veterinary case report
Bioprosthetic valve surgery helps dogs with tricuspid valve defects
By Arai, Shiori et al.·Published in Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology·2011·Department of Clinical Sciences, United States·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Bioprosthesis valve replacement in dogs with congenital tricuspid valve dysplasia: technique and outcome.
- Species:
- dog
Plain-English summary
Twelve dogs with severe heart problems due to a congenital issue with their tricuspid valve underwent surgery to replace the valve with a bioprosthesis made from animal tissue. Most of the dogs survived the surgery and were able to go home, with seven of them living without heart issues for an average of four years afterward. However, two dogs had to be euthanized due to complications with the new valve, and others experienced issues like valve clots or infections, which were treated successfully. Preventive medication before surgery helped reduce serious heart rhythm problems in some dogs.
People also search for: dog heart surgery recovery · tricuspid valve replacement in dogs · dog heart valve problems treatment
Abstract
OBJECTIVE: To describe the surgical technique and report outcome of dogs undergoing bioprosthesis valve replacement for severe tricuspid regurgitation (TR) secondary to congenital tricuspid valve dysplasia (TVD). ANIMALS, MATERIALS AND METHODS: Twelve client-owned dogs (19-43 kg) with TVD underwent tricuspid valve replacement with a bovine pericardial or porcine aortic bioprosthesis with the aid of cardiopulmonary bypass. Anticoagulation with warfarin was maintained for 3 months after surgery and then discontinued. RESULTS: Ten of 12 (83.3%) dogs survived surgery and were discharged from the hospital. Seven dogs were alive with complete resolution of TR for a median period of 48 months (range 1-66 months) after surgery. Two dogs underwent euthanasia because of bioprosthesis failure due to inflammatory pannus at 10 and 13 months after surgery. Two dogs experienced valve thrombosis that was resolved by tissue plasminogen activator. One dog developed suspected endocarditis after surgery that was resolved with antibiotics. Serious cardiac complications included atrial fibrillation and flutter, right-to-left shunt through an uncorrected patent foramen ovale, complete atrioventricular block, and sudden cardiac arrest. Postoperative atrial fibrillation or flutter did not occur in 7 dogs treated prophylactically with oral amiodarone before surgery. CONCLUSIONS: Curative intermediate-term outcomes are possible in dogs undergoing open tricuspid valve replacement with a bioprosthesis. Prosthesis-related complications include inflammatory pannus, thrombosis, and endocarditis. Postoperative atrial fibrillation or flutter can be reduced or prevented by prophylactic preoperative treatment with amiodarone. Several identified complications are avoidable or can be reduced with increased awareness and experience with these techniques.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/21640677/